Metabolism of drugs and other xenobiotics in giant liver fluke (Fascioloides magna)

References

• Alvarez LI, Solana HD, Mottier ML, et al. (1997). Helminth detoxification mechanisms. J Helminthol 71:85–9
   PubMed Web of Science ®Google Scholar
• Alvarez LI, Solana HD, Mottier ML, et al. (2005). Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 131:501--10
   Google Scholar
• Bártíková H, Krízová V, Lamka J, et al. (2010a). Flubendazole metabolism and biotransformation enzymes activities in healthy sheep and sheep with haemonchosis. J Vet Pharmacol Ther 33:56–62
   PubMed Web of Science ®Google Scholar
• Bártíková H, Vokřál I, Skálová L, et al. (2010b). In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo. Xenobiotica 40:593–601
   PubMed Web of Science ®Google Scholar
• Bártíková H, Vokřál I, Skálová L, et al. (2012). The activity of drug-metabolizing enzymes and the biotransformation of selected anthelmintics in the model tapeworm Hymenolepis diminuta. Parasitology 139:809–18
   PubMed Web of Science ®Google Scholar
• Brennan GP, Fairweather I, Trudgett A, et al. (2007). Understanding triclabendazole resistance. Exp Mol Pathol 82:104–9
   PubMed Web of Science ®Google Scholar
• Brophy PM, Crowley P, Barrett J. (1990). Relative distribution of glutathione transferase, glyoxalase I and glyoxalase II in helminths. Int J Parasitol 20:259–61
   PubMed Web of Science ®Google Scholar
• Brophy PM, MacKintosh N, Morphew RM. (2012). Anthelmintic metabolism in parasitic helminths: proteomic insights. Parasitology 139:1205–17
   PubMed Web of Science ®Google Scholar
• Burke MD, Thompson S, Weaver RJ, et al. (1994). Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48:923–36
   PubMed Web of Science ®Google Scholar
• Cashman JR, Hanzlik RP. (1981). Microsomal oxidation of thiobenzamide. A photometric assay for the flavin-containing monooxygenase. Biochem Biophys Res Commun 98:147–53
   PubMed Web of Science ®Google Scholar
• Cullen JJ, Hinkhouse MM, Grady M, et al. (2003). Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res 63:5513–20
   PubMed Web of Science ®Google Scholar
• Cvilink V, Kubíček V, Nobilis M, et al. (2008). Biotransformation of flubendazole and selected model xenobiotics in Haemonchus contortus. Vet Parasitol 151:242–8
   PubMed Web of Science ®Google Scholar
• Cvilink V, Lamka J, Skálová L. (2009a). Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths. Drug Metab Rev 41:8–26
   PubMed Web of Science ®Google Scholar
• Cvilink V, Szotáková B, Krízová V, et al. (2009c). Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum). Res Vet Sci 86:49–55
   PubMed Web of Science ®Google Scholar
• Cvilink V, Szotáková B, Vokrál I, et al. (2009b). Liquid chromatography/mass spectrometric identification of benzimidazole anthelminthics metabolites formed ex vivo by Dicrocoelium dendriticum. Rapid Commun Mass Spectrom 23:2679–84
   PubMed Web of Science ®Google Scholar
• Dayan A. (2003). Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop 86:141–59
   PubMed Web of Science ®Google Scholar
• Dedek W, Grahl R, Schwarz H, Ludwig P. (1978). Metabolism, residue and excretion of the anthelmintic 131 I-rafoxanide in blood, milk, meat and urine of lactating cows. Arch Exp Veterinarmed 32:951–5
   PubMedGoogle Scholar
• Demiaszkiewicz A. (2005). Helminty i wywoływane przez nie helmintozy dzikich przeżuwaczy. Kosm Probl Nauk Biol 55:61–71
   Google Scholar
• Devine C, Brennan GP, Lanusse CE, et al. (2012). Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole. Vet Parasitol 184:37–47
   PubMed Web of Science ®Google Scholar
• EMEA-European Medicines Evaluation Agency. (2001). Mebendazole summary report (2) by CVMP, EMEA/MRL/781/01-FINAL. EMEA
   Google Scholar
• EMEA-European Medicines Evaluation Agency. (2014). Rafoxanide (bovine and ovine milk), European public MRL assessment report by CVMP (EPMAR)EMA/CVMP/592866/2013. EMEA
   Google Scholar
• Fitzsimmons SA, Workman P, Grever M, et al. (1996). Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst 88:259–69
   PubMed Web of Science ®Google Scholar
• Flohé L, Günzler WA. (1984). Assays of glutathione peroxidase. Methods Enzymol 105:114–21
   PubMed Web of Science ®Google Scholar
• Frame LT, Ozawa S, Nowell SA, et al. (2000). A simple colorimetric assay for phenotyping the major human thermostable phenol sulfotransferase (SULT1A1) using platelet cytosols. Drug Metab Dispos 28:1063–8
   PubMed Web of Science ®Google Scholar
• Galtier P, Coulet M, Sutra JF, et al. (1994). Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep. Exp Parasitol 79:166–76
   PubMed Web of Science ®Google Scholar
• Gibson GG, Skett P. (2001). Introduction to drug metabolism. Cheltenham, UK: Nelson Thornes
   Google Scholar
• Góth L. (1991). A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 196:143–51
   PubMed Web of Science ®Google Scholar
• Habig WH, Jakoby WB. (1981). Glutathione S-transferases (rat and human). Methods Enzymol 77:218–31
   PubMedGoogle Scholar
• Handy DE, Lubos E, Yang Y, et al. (2009). Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. J Biol Chem 284:11913–21
   PubMed Web of Science ®Google Scholar
• Hennessy DR, Lacey E, Steel JW, Prichard RK. (1987). The kinetics of triclabendazole disposition in sheep. J Vet Pharmacol Ther 10:64–72
   PubMed Web of Science ®Google Scholar
• James CE, Hudson AL, Davey MW. (2009). Drug resistance mechanisms in helminths: is it survival of the fittest? Trends Parasitol 25:328–35
   PubMed Web of Science ®Google Scholar
• Kasny M, Beran L, Siegelova V, et al. (2012). Geographical distribution of the giant liver fluke (Fascioloides magna) in the Czech Republic and potential risk of its further spread. Vet Med (Praha) 57:101–9
   Web of Science ®Google Scholar
• Kotze AC. (1997). Cytochrome P450 monooxygenase activity in Haemonchus contortus (Nematoda). Int J Parasitol 27:33–40
   PubMed Web of Science ®Google Scholar
• Králová-Hromadová I, Bazsalovicsová E, Stefka J, et al. (2011). Multiple origins of European populations of the giant liver fluke Fascioloides magna (Trematoda: Fasciolidae), a liver parasite of ruminants. Int J Parasitol 41:373–83
   PubMed Web of Science ®Google Scholar
• Laing R, Kikuchi T, Martinelli A, et al. (2013). The genome and transcriptome of Haemonchus contortus, a key model parasite for drug and vaccine discovery. Genome Biol 14:R88
   PubMed Web of Science ®Google Scholar
• Majoros G, Sztojkov V. (1994). Appearance of the large American liver fluke Fascioloides magna (Bassi. (1875)) (Trematoda: Fasciolata) in Hungary. Parasitol Hungarica 27:27–38
   Google Scholar
• Marinculić A, Nikola D, Janicki Z, Tatjana Ž. (2002). Appearance of American liver fluke (Fascioloides magna, Bassi. (1875)) in Croatia – a case report. Vet Arh 72:319–25
   Google Scholar
• Maser E. (1995). Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochem Pharmacol 49:421–40
   PubMed Web of Science ®Google Scholar
• Maté, L, Virkel G, Lifschitz A, et al. (2008). Hepatic and extra-hepatic metabolic pathways involved in flubendazole biotransformation in sheep. Biochem Pharmacol 76:773–83
   PubMed Web of Science ®Google Scholar
• Michiels M, Meuldermans W, Heykants J. (1987). The metabolism and fate of closantel (Flukiver) in sheep and cattle. Drug Metab Rev 18:235–51
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Norbury HM, Waring RH, et al. (1982). A comparison of the metabolism and elimination of benzanilide and salicylanilide in the rat. Xenobiotica 12:93–9
   PubMed Web of Science ®Google Scholar
• Mizuma T, Machida M, Hayashi M, Awazu S. (1982). Correlation of drug conjugative metabolism rates between in vivo and in vitro: glucuronidation and sulfation of p-nitrophenol as a model compound in rat. J Pharmacobiodyn 5:811–17
   PubMedGoogle Scholar
• Mottier L, Virkel G, Solana HD, et al. (2004). Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica. Xenobiotica 34:1043–57
   PubMed Web of Science ®Google Scholar
• Novobilský A, Horácková E, Hirtová L, et al. (2007). The giant liver fluke Fascioloides magna (Bassi 1875) in cervids in the Czech Republic and potential of its spreading to Germany. Parasitol. Res 100:549–53
   PubMed Web of Science ®Google Scholar
• Ohara H, Miyabe Y, Deyashiki Y, Matsuura K, Kara A. (1995). Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochem Pharmacol 50:221–7
   PubMed Web of Science ®Google Scholar
• Palackal NT, Burczynski ME, Harvey RG, Penning TM. (2001). Metabolic activation of polycyclic aromatic hydrocarbon trans-dihydrodiols by ubiquitously expressed aldehyde reductase (AKR1A1). Chem Biol Interact 130–132:815–24
   PubMed Web of Science ®Google Scholar
• Pérez F. (2002). Ascorbic acid and flavonoid-peroxidase reaction as a detoxifying system of H2O2 in grapevine leaves. Phytochemistry 60:573–80
   PubMed Web of Science ®Google Scholar
• Precious WY, Barrett J. (1989). Xenobiotic metabolism in helminths. Parasitol Today 5:156–60
   PubMedGoogle Scholar
• Preyavichyapugdee N, Sahaphong S, Riengrojpitak S, et al. (2008). Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice. Exp Parasitol 119:229–37
   PubMed Web of Science ®Google Scholar
• Prchal L, Bártíková H, Bečanová A, et al. (2015). Biotransformation of anthelmintics and the activity of drug-metabolizing enzymes in the tapeworm Moniezia expansa. Parasitology 142:648–59
   PubMed Web of Science ®Google Scholar
• Pybus M. (2001). Parasitic diseases of wild mammals. Ames (IA): Iowa State University Press
   Google Scholar
• Rajković-Janje R, Bosnić, S, Rimac D, Gojmerac T. (2008). The prevalence of American liver fluke Fascioloides magna (Bassi 1875) in red deer from Croatian hunting grounds. Eur J Wildl Res 54:525–8
   Web of Science ®Google Scholar
• Rajský, D, Čorba J, Varady M, et al. (2002). Control of fascioloidosis Fascioloides magna Bassi. (1875) in red deer and roe deer. Helminthologia 39:67–70
   Web of Science ®Google Scholar
• Rawden HC, Kokwaro GO, Ward SA, Edwards G. (2000). Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br J Clin Pharmacol 49:313–22
   PubMed Web of Science ®Google Scholar
• Robinson MW, Lawson J, Trudgett A, et al. (2004). The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol Res 92:205–10
   PubMed Web of Science ®Google Scholar
• Rothwell J, Sangster N. (1997). Haemonchus contortus: the uptake and metabolism of closantel. Int J Parasitol 27:313–19
   PubMed Web of Science ®Google Scholar
• Saeed HM, Mostafa MH, O’Connor PJ, et al. (2002). Evidence for the presence of active cytochrome P450 systems in Schistosoma mansoni and Schistosoma haematobium adult worms. FEBS Lett 519:205–9
   PubMed Web of Science ®Google Scholar
• Sattmann H, Hörweg C, Gaub L, et al. (2014). Wherefrom and whereabouts of an alien: the American liver fluke Fascioloides magna in Austria: an overview. Wien Klin Wochenschr 126:S23–31
   PubMed Web of Science ®Google Scholar
• Sexton JL, Milner AR, Panaccio M, et al. (1990). Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep. J Immunol 145:3905–10
   PubMed Web of Science ®Google Scholar
• Skálová L, Cvilink V, Bártíková H, et al. (2010). Biotransformation of Xenobiotics in Lancet Fluke (Dicrocoelium dendriticum). In: LaMann GV, ed. Veterinary parasitology. Hauppauge (NY):NOVA Publishers, 1–20
   Google Scholar
• Smith PK, Krohn RI, Hermanson GT, et al. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
   PubMed Web of Science ®Google Scholar
• Solana HD, Rodriguez JA, Lanusse CE. (2001). Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Parasitol Res 87:275–80
   PubMed Web of Science ®Google Scholar
• Stuchlíková L, Jirásko R, Vokřál I, et al. (2013). Investigation of the metabolism of monepantel in ovine hepatocytes by UHPLC/MS/MS. Anal Bioanal Chem 405:1705–12
   PubMed Web of Science ®Google Scholar
• Swan GE. (1999). The pharmacology of halogenated salicylanilides and their anthelmintic use in animals. J S Afr Vet Assoc 70:61–70
   PubMed Web of Science ®Google Scholar
• Vokřál I, Bártíková, H, Prchal L, et al. (2012). The metabolism of flubendazole and the activities of selected biotransformation enzymes in Haemonchus contortus strains susceptible and resistant to anthelmintics. Parasitology 139:1309–16
   PubMed Web of Science ®Google Scholar
• Vokřál I, Jirásko R, Stuchlíková L, et al. (2013). Biotransformation of albendazole and activities of selected detoxification enzymes in Haemonchus contortus strains susceptible and resistant to anthelmintics. Vet Parasitol 196:373–81
   PubMed Web of Science ®Google Scholar
• Winkelmayer R, Prosl H. (2001). Riesenleberegel – jetzt auch bei uns? Österreichisches Weidw 3:42–4
   Google Scholar
• Yang YS, Marshall AD, McPhie P, et al. (1996). Two phenol sulfotransferase species from one cDNA: nature of the differences. Protein Expr Purif 8:423–9
   PubMed Web of Science ®Google Scholar